Not only have asthma attack rates decreased during the pandemic, evidence suggests people with asthma are not at increased risk of severe outcomes from COVID.
Academic rigor, journalistic flair
Articles on Dexamethasone
Displaying all articles
Medications to treat COVID-19 are in no way a substitute for the vaccine. But under the right circumstances, some show great promise for helping patients.
A lack of medicines manufacturing capability in Australia puts us at significant risk.
Monoclonal antibodies are synthetic molecules manufactured in the lab. But do we need them if a vaccine is on its way?
Death rates for hospitalized COVID-19 patients fell from 25.6% in March to 7.6% in August, according to a new study on three hospitals in New York. A study in the UK found similar results.
There’s still a lot of uncertainty, but the picture is gradually getting clearer – here’s what we know so far.
The long-awaited study of the coronavirus drug, remdesivir, has just been published.
The president and first lady Melania Trump have both tested positive for the coronavirus. Here’s what the physicians and scientists know about the best treatments for the disease it causes.
Hydrocortisone – a common remedy for eczema – joins dexamethasone as a proven treatment for the worst cases of coronavirus.
Common and cheap drugs save lives of patients critically ill with COVID-19, a new analysis shows. But these corticosteroids are not a cure.
Most people diagnosed with COVID-19 can manage their illness at home. But some patients deteriorate after about 5 days. Fortunately, Australian doctors have up-to-the-minute treatment guidelines.
Treatment nationalism is a threat to us all.
During the last six months, news reports have mentioned dozens of drugs that may be effective against the new coronavirus. Here we lay out the evidence and reveal which ones are proven to work. Or not.
Scientists have discovered that a widely used, cheap steroid can fight off COVID-19 in the most severe cases. Here’s how it works.
Top contributors
-
Senior Lecturer in Pharmacology, Keele University
-
Professor of Medicine, University of Virginia
-
Associate Professor of the Sydney Pharmacy School, University of Sydney
-
Communications Manager and Researcher, Cochrane Australia/Cochrane Collaboration, Monash University
-
Executive Director, National COVID-19 Clinical Evidence Taskforce, and Professor, School of Public Health and Preventive Medicine, Monash University
-
Head of School and Dean of Pharmacy, University of Sydney
-
Senior Lecturer in Chemical Pathology, University of Westminster
-
Head of School of Medicine, Anglia Ruskin University
-
Professor of Medicine, Division of HIV, Infectious Diseases and Global Medicine, University of California, San Francisco
-
Professor of International Governance, University of Leeds
-
Pharmacist and PhD Candidate, University of Sydney
-
Assistant Professor of Medicine, University of Virginia
-
Regents' Professor of Clinical Laboratory Science, Texas State University
-
Associate Professor in Pharmaceutical Sciences, School of Pharmacy, University of Sydney
-
Professor and Dean of the School of Health Sciences, Swinburne University of Technology
